Cancer experts back Express campaign for neuroblastoma vaccine research
Leading experts have backed a Daily Express campaign for Britain to fund research into a promising cancer vaccine that could save hundreds of young lives. (Source: Daily Express - Health)
Source: Daily Express - Health - January 16, 2023 Category: Consumer Health News Source Type: news

FDA Panel: All Thumbs Down for Antibody to Treat Metastatic Neuroblastoma
(MedPage Today) -- An FDA advisory committee voted unanimously against recommending approval of the radiolabeled monoclonal antibody 131I-omburtamab for progressive neuroblastoma with central nervous system (CNS)/leptomeningeal metastases. Citing... (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 28, 2022 Category: American Health Source Type: news

What is Ondine ’ s Curse?
Discussion Congenital central hypoventilation syndrome (CCHS) is an autosomal dominant with variable inheritance genetic disease caused by mutation in the Paired Like Homeobox B2 (PHOX2B) gene on chromosome 4. There are two other genes which may also cause CCHS. CCHS affects the chemoreceptor afferent ventilation pathways and is a neural crest migration problem of the autonomic nervous system. The incidence is unknown but a prevalence of 1 in 200,000 live births has been reported. Obviously it is a rarer phenomenon because of the general lethality of the syndrome. Patients usually present at birth or soon afterwards, but o...
Source: PediatricEducation.org - August 15, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Neuromics' Human Neurons in Action
Our primary human neurons (cat. HNC001) have been busy lately, continuing to become one of our most popular and versatile products. Earlier this month, Japanese researchers published their findings when creating 3D brain-like spheroids containing our primary human neurons. Their results suggest the spheroids mimic in vivo conditions and are suitable for use as an in vitro neurological disease model. Check out the publication for yourself here.Human Neurons in CultureSince the beginning of 2022, our neurons have been cited a number of times spanning various research are...
Source: Neuromics - July 29, 2022 Category: Neuroscience Source Type: news

'Bridge' Therapy May Benefit Some Kids With High-Risk Neuroblastoma
(MedPage Today) -- Bridge therapy ahead of autologous stem cell transplantation (ASCT) consolidation may benefit certain high-risk neuroblastoma patients with residual disease following induction regimens, according to a multicenter retrospective... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - June 22, 2022 Category: Hematology Source Type: news

Bridge Therapy Between Induction, ASCT May Slow Neuroblastoma
Three - year event - free survival significantly improved for patients with end - induction stable metastatic disease receiving bridge therapy (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 6, 2022 Category: Cancer & Oncology Tags: Neurology, Oncology, Pathology, Pediatrics, Journal, Source Type: news

Bridge Therapy Between Induction, ASCT May Slow Neuroblastoma
MONDAY, June 6, 2022 -- For patients with high-risk neuroblastoma with end-induction stable metastatic disease, postinduction bridge therapy before autologous stem cell transplantation (ASCT) is associated with better outcomes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 6, 2022 Category: Pharmaceuticals Source Type: news

Cancer Outcome Disparities Not Fully Explained by Race, Socioeconomic Factors
(MedPage Today) -- Enrollment in clinical trials failed to overcome factors leading to worse survival for Hispanic children with high-risk neuroblastoma, a large retrospective analysis showed. The Hispanic subgroup had a 5-year overall survival... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - May 27, 2022 Category: Hematology Source Type: news

Clarity launching trial for prostate cancer therapy
Clarity Pharmaceuticals is launching an investigator-initiated trial that wil...Read more on AuntMinnie.comRelated Reading: Clarity hits milestone in study of radiopharmaceutical NorthStar partners with Clarity, Monopar FDA grants rare disease designation to Clarity agent Clarity's breast imaging agent enters clinical trial Clarity begins trial for pediatric neuroblastoma therapy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - March 24, 2022 Category: Radiology Source Type: news

The cancer vaccine that saved our boy should be free on the NHS
WHEN Claire and Mike Scott's three-year-old son was diagnosed with neuroblastoma their world fell apart. Hearts breaking, they had to watch as little Liam went through a whole year of gruelling procedures - chemotherapy, surgery, radiotherapy, immunotherapy and bone marrow treatment. (Source: Daily Express - Health)
Source: Daily Express - Health - February 8, 2022 Category: Consumer Health News Source Type: news

Parents of girl, 4, who is battling rare neuroblastoma cancer are raising £250,000
Florentina Burton, from Braintree, Essex, was diagnosed with neuroblastoma in May last year, after doctors found a tumour on her kidney. (Source: the Mail online | Health)
Source: the Mail online | Health - January 16, 2022 Category: Consumer Health News Source Type: news

Clarity hits milestone in study of radiopharmaceutical
Radiopharmaceutical developer Clarity Pharmaceuticals has completed patien...Read more on AuntMinnie.comRelated Reading: NorthStar partners with Clarity, Monopar Clarity's breast imaging agent enters clinical trial Clarity begins trial for pediatric neuroblastoma therapy Clarity, ImaginAb team to develop theranostic agents NorthStar inks supply deal with Clarity (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 11, 2021 Category: Radiology Source Type: news

Safety concerns raised for neuroblastoma candidate drug
St. Jude Children's Research Hospital scientists looking for drugs to improve survival of children with high-risk neuroblastoma found a promising candidate in CX-5461. Then researchers identified safety concerns with the experimental drug that have implications for current clinical trials in adults. The study appears today in Nature Communications. (Source: World Pharma News)
Source: World Pharma News - November 9, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Therapy using dual immune system cells effectively controls neuroblastoma
A newly developed immunotherapy that simultaneously uses modified immune-fighting cells to home in on and attack two antigens, or foreign substances, on cancer cells was highly effective in mice implanted with human neuroblastoma tissue, report researchers from the UNC Lineberger Comprehensive Cancer Center and the UNC School of Medicine. (Source: World Pharma News)
Source: World Pharma News - September 23, 2021 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Consumer Health: Childhood cancer
September is Childhood Cancer Awareness Month, which makes this a good time to learn about three of the most common types of cancers in children: acute lymphocytic leukemia, neuroblastoma and pediatric brain tumors. Acute lymphocytic leukemia Acute lymphocytic leukemia is a cancer of the blood and bone marrow. It's the most common type of cancer in children, and treatments result in a good chance for a cure. Acute lymphocytic leukemia also can occur in adults, though… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - September 6, 2021 Category: Databases & Libraries Source Type: news